Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases

D. Cortinovis, R. Chiari, A. Catino, F. Grossi, F.D.E. Marinis, F. Sperandi, F. Piantedosi, M. Vitali, H.J. Soto Parra, M.R. Migliorino, C. Tondini, D. Tassinari, A. Frassoldati, F. Verderame, A. Pazzola, F. Cognetti, G. Palmiotti, P. Marchetti, A. Santoro, D. GiannarelliF. Colonese, A. Delmonte

Research output: Contribution to journalArticle

Original languageItalian
Pages (from-to)4265-4271
Number of pages7
JournalAnticancer Research
Volume39
Issue number8
DOIs
Publication statusPublished - 2019

Cite this

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., Marinis, F. D. E., Sperandi, F., Piantedosi, F., Vitali, M., Soto Parra, H. J., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., ... Delmonte, A. (2019). Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases. Anticancer Research, 39(8), 4265-4271. https://doi.org/10.21873/anticanres.13590